Paper41348871
Programmable multistep CRISPR gene activation via control of RNA polymerase III termination.
Puppala AK and 10 others. Sci Adv, 2025. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Programmable multistep CRISPR gene activation via control of RNA polymerase III termination. Papers, record 41348871. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41348871
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Programmable multistep CRISPR gene activation via control of RNA polymerase III termination.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| RNA Polymerase III | Major topic |
| CRISPR-Cas Systems | Major topic |
| Transcriptional Activation | Major topic |
| Clustered Regularly Interspaced Short Palindromic Repeats | Major topic |
| Humans | |
| Gene Editing | |
| Induced Pluripotent Stem Cells | |
| HEK293 Cells |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R01 GM139894 | NIGMS NIH HHS | United States | R01GM139894 | PubMed and NIH |
Source NIH RePORTER
References63
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34348480 | Advances in the Development and the Applications of Nonviral, Episomal Vectors for Gene Therapy. | Hum Gene Ther | 2021 | https://conductscience.org/library/papers/34348480 | PubMed |
| 2 | 26735016 | High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects. | Nature | 2016 | https://conductscience.org/library/papers/26735016 | PubMed |
| 3 | 29084946 | Drug-tunable multidimensional synthetic gene control using inducible degron-tagged dCas9 effectors. | Nat Commun | 2017 | https://conductscience.org/library/papers/29084946 | PubMed |
| 4 | 38569552 | Lineage-tracing hematopoietic stem cell origins in vivo to efficiently make human HLF+ HOXA+ hematopoietic progenitors from pluripotent stem cells. | Dev Cell | 2024 | https://conductscience.org/library/papers/38569552 | PubMed |
| 5 | 24360272 | Dynamic imaging of genomic loci in living human cells by an optimized CRISPR/Cas system. | Cell | 2013 | https://conductscience.org/library/papers/24360272 | PubMed |
| 6 | 30405244 | Predictable and precise template-free CRISPR editing of pathogenic variants. | Nature | 2018 | https://conductscience.org/library/papers/30405244 | PubMed |
| 7 | 15930108 | The circuitry of a master switch: Myod and the regulation of skeletal muscle gene transcription. | Development | 2005 | https://conductscience.org/library/papers/15930108 | PubMed |
| 8 | 28333914 | Genome-scale CRISPR-Cas9 knockout and transcriptional activation screening. | Nat Protoc | 2017 | https://conductscience.org/library/papers/28333914 | PubMed |
| 9 | 27661255 | Compact and highly active next-generation libraries for CRISPR-mediated gene repression and activation. | Elife | 2016 | https://conductscience.org/library/papers/27661255 | PubMed |
| 10 | 26628643 | Rationally engineered Cas9 nucleases with improved specificity. | Science | 2016 | https://conductscience.org/library/papers/26628643 | PubMed |
| 11 | 33811918 | RNA Sequence and Structure Determinants of Pol III Transcriptional Termination in Human Cells. | J Mol Biol | 2021 | https://conductscience.org/library/papers/33811918 | PubMed |
| 12 | 30033371 | Precise and Predictable CRISPR Chromosomal Rearrangements Reveal Principles of Cas9-Mediated Nucleotide Insertion. | Mol Cell | 2018 | https://conductscience.org/library/papers/30033371 | PubMed |
| 13 | 23892895 | RNA-guided gene activation by CRISPR-Cas9-based transcription factors. | Nat Methods | 2013 | https://conductscience.org/library/papers/23892895 | PubMed |
| 14 | 30340517 | Harnessing accurate non-homologous end joining for efficient precise deletion in CRISPR/Cas9-mediated genome editing. | Genome Biol | 2018 | https://conductscience.org/library/papers/30340517 | PubMed |
| 15 | 31403072 | Conditional Guide RNAs: Programmable Conditional Regulation of CRISPR/Cas Function in Bacterial and Mammalian Cells via Dynamic RNA Nanotechnology. | ACS Cent Sci | 2019 | https://conductscience.org/library/papers/31403072 | PubMed |
| 16 | 26344044 | Cas9 gRNA engineering for genome editing, activation and repression. | Nat Methods | 2015 | https://conductscience.org/library/papers/26344044 | PubMed |
| 17 | 25513782 | GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases. | Nat Biotechnol | 2015 | https://conductscience.org/library/papers/25513782 | PubMed |
| 18 | 16904174 | Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. | Cell | 2006 | https://conductscience.org/library/papers/16904174 | PubMed |
| 19 | 38372898 | Targeted CRISPR activation is functional in engineered human pluripotent stem cells but undergoes silencing after differentiation into cardiomyocytes and endothelium. | Cell Mol Life Sci | 2024 | https://conductscience.org/library/papers/38372898 | PubMed |
| 20 | 23396014 | Synthetic circuits integrating logic and memory in living cells. | Nat Biotechnol | 2013 | https://conductscience.org/library/papers/23396014 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41348871
GET https://conductscience.org/api/papers/v1/41348871/references?page=2